YLZ(300096)

Search documents
ST易联众:关于收到中国证券监督管理委员会立案告知书的公告
2024-05-08 10:53
截至本公告披露日,公司经营情况正常,各项业务正在稳步推进中。立案调 查期间,公司将积极配合中国证监会的相关工作,并严格按照相关法律法规的规 定及时履行信息披露义务。 公司指定的信息披露媒体为《中国证券报》《上海证券报》《证券时报》《证 券日报》及巨潮资讯网(http://www.cninfo.com.cn),公司所有重大信息均以公 司在上述指定媒体披露的公告为准。敬请广大投资者谨慎决策,注意投资风险。 特此公告。 易联众信息技术股份有限公司 关于收到中国证券监督管理委员会立案告知书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 易联众信息技术股份有限公司(以下简称"公司")于 2024 年 5 月 8 日收到 中国证券监督管理委员会(以下简称"中国证监会")下发的《立案告知书》(编 号:证监立案字 0282024004 号)。因公司涉嫌未按规定披露为关联方提供担保等 信息披露违法违规,根据《中华人民共和国证券法》《中华人民共和国行政处罚 法》等法律法规,中国证监会决定对公司立案。 易联众信息技术股份有限公司 证券代码:300096 证券简称:ST易联众 ...
ST易联众:关于公司股票被实施其他风险警示相关事项的进展公告
2024-05-06 08:44
证券代码:300096 证券简称:ST易联众 公告编号:2024-026 易联众信息技术股份有限公司 关于公司股票被实施其他风险警示相关事项的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 根据《深圳证券交易所创业板股票上市规则》相关规定,因易联众信息技术 股份有限公司(以下简称"公司")所涉相关违规担保、违规借款情形尚未消除, 公司股票将继续被实施其他风险警示(ST)。 一、公司被实施其他风险警示的原因 公司于 2023 年 11 月 28 日披露了《关于存在违规担保、违规借款暨公司涉 及重大诉讼及仲裁事项的公告》(公告编号:2023-077),经自查,公司发现存在 未履行任何内控审批/董事会/股东大会审议决策程序,为原实际控制人/控股股 东/时任董事长张曦先生及其关联方提供违规担保,以及张曦先生以公司名义签 署违规借款的情形。截至本公告披露日,公司相关违规担保、违规借款事项尚未 消除。 根据《深圳证券交易所创业板股票上市规则》第 9.4 条、第 9.5 条相关规 定,公司股票被实施其他风险警示。具体详见公司于 2023 年 12 月 29 日、2 ...
ST易联众:关于违规事项涉及重大诉讼的进展公告
2024-04-29 09:34
证券代码:300096 证券简称:ST易联众 公告编号:2024-025 易联众信息技术股份有限公司 关于违规事项涉及重大诉讼的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 特别提示: 1.案件所处的诉讼阶段:二审 2.公司所处的当事人地位:上诉人 3.涉案的金额:借款本金 5,000 万元(人民币,下同)及相关利息、债权人 律师费、案件受理费等 4.对公司的影响:截至本公告披露日,本次诉讼尚未开庭审理,诉讼最终结 果和对公司本期利润或期后利润的影响尚存在不确定性。 如果未按本判决指定的期间履行给付金钱义务,应当依照《中华人民共和国 民事诉讼法》第二百六十四条之规定,加倍支付迟延履行期间的债务利息。 案件受理费 326,431 元,由高彩娥负担 1,909 元,公司、张曦、张华芳负担 324,522 元。 敬请广大投资者谨慎决策,理性投资,注意风险。 近日,易联众信息技术股份有限公司(以下简称"公司")收到浙江省杭州 市中级人民法院(以下简称"杭州中院")出具的《传票》(案号:(2024)浙 01 民终 4410 号),杭州中院受理公司与高彩娥女士 ...
ST易联众(300096) - 2023 Q4 - 年度财报
2024-04-25 16:50
Financial Performance - The company reported a significant increase in revenue, achieving a total of 1.2 billion yuan, representing a year-over-year growth of 15%[3]. - The company reported a total revenue of RMB 1.2 billion for the fiscal year 2023, representing a year-over-year increase of 15% compared to RMB 1.04 billion in 2022[19]. - The company's operating revenue for 2023 was ¥797,422,578.13, representing a 47.90% increase compared to ¥539,169,940.15 in 2022[26]. - The net profit attributable to shareholders for 2023 was ¥37,049,464.80, a significant increase of 111.58% from ¥319,821,325.05 in 2022[26]. - The company reported a total revenue of 4.395 billion in 2023, representing a year-on-year increase of 62%[142]. - The company reported a total revenue of 1.5 billion RMB for the fiscal year 2023, representing a year-over-year increase of 15%[174]. - The company’s revenue from the insurance brokerage sector surged by 148.04%, reaching ¥7,496,849.31, up from ¥3,022,385.29 in 2022[83]. - The company’s revenue from the other services category increased by 96.92%, amounting to ¥13,282,817.79 compared to ¥6,745,457.32 in the previous year[83]. User Growth and Engagement - User data showed an increase in active users, reaching 5 million, which is a 20% increase compared to the previous year[3]. - User data showed an increase in active users to 5 million, up from 4 million in the previous year, marking a growth of 25%[19]. - The user base grew to 8.833 million, marking a significant increase of 71.3% compared to the previous year[142]. - User data showed an increase in active users by 20% year-over-year, reaching 10 million active users by the end of Q4 2023[174]. Future Outlook and Projections - The company has provided a positive outlook for the next fiscal year, projecting a revenue growth of 10% to 15%[3]. - The company has set a revenue guidance for 2024, projecting a growth rate of 20% to reach approximately RMB 1.44 billion[19]. - The company anticipates a revenue guidance of 5 billion for the next fiscal year, indicating a projected growth of approximately 14%[143]. - The company expects revenue growth to continue at a rate of 10-15% for the next fiscal year, driven by new product launches and market expansion[162]. Research and Development - Research and development investments have increased by 30%, totaling 150 million yuan, aimed at enhancing technology capabilities[3]. - Research and development expenses increased by 18% to RMB 150 million, focusing on AI and machine learning technologies[19]. - The company is investing 50 million in R&D for new technologies aimed at enhancing user experience[157]. - Investment in R&D increased by 20% compared to the previous year, focusing on AI and cloud technology innovations[163]. Market Expansion and Strategy - The company is focusing on market expansion, targeting a 25% increase in market share in the healthcare sector[3]. - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by the end of 2024[19]. - The company plans to expand its market presence through strategic partnerships and acquisitions, particularly in the health management sector[144]. - Market expansion plans include entering two new regions, projected to increase market share by 5%[157]. Strategic Acquisitions - The company plans to explore strategic acquisitions to bolster its service offerings, with a budget of 500 million yuan allocated for potential deals[3]. - A strategic acquisition of a local tech firm was completed in Q3 2023, expected to enhance the company's technological capabilities and add approximately RMB 200 million in annual revenue[19]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 100 million allocated for potential deals[157]. - The company has completed a strategic acquisition of a tech startup for 500 million RMB to bolster its product offerings[174]. Operational Efficiency and Cost Management - The company has successfully reduced operational costs by 12% through efficiency improvements and process optimizations[19]. - The company plans to implement cost-cutting measures expected to save 30 million annually[157]. - The company aims to enhance operational efficiency by implementing new management strategies and restructuring initiatives[144]. - The company aims to reduce operational costs by 10% through efficiency improvements in the next fiscal year[162]. Governance and Compliance - The company has established a strict compliance framework in accordance with regulatory requirements from the China Securities Regulatory Commission[176]. - The company maintains a complete and independent business system, with no reliance on the controlling shareholder for operations[135]. - The company has held multiple shareholder meetings, ensuring compliance with legal regulations and providing equal treatment to all shareholders[131]. - The board of directors consists of 10 members, including 4 independent directors, and held 6 meetings during the reporting period[133]. Technology and Innovation - The company is actively exploring the application of AI, blockchain, and big data technologies to support digital transformation in healthcare and social security sectors[55]. - The company has developed a comprehensive hospital information system that integrates various modules including electronic medical records, clinical pathways, and quality control management, significantly enhancing operational efficiency[54]. - The company is committed to continuous technological innovation to meet customer needs and improve service satisfaction[200]. - The company is focusing on technological advancements and new product development to enhance its market position[165]. Customer Satisfaction and Service Enhancement - Customer satisfaction ratings improved to 90%, reflecting a 5% increase from the last quarter[157]. - The company has established a comprehensive customer-centric after-sales service system to effectively respond to customer needs and enhance staff accountability[124]. - The company has achieved a high customer satisfaction rate through over 20 years of deep engagement in the livelihood sector, receiving appreciation from various government departments and partners[72]. - The company aims to maintain a competitive edge by aligning its compensation strategy with industry standards[167]. Employee Management and Development - The total number of employees at the end of the reporting period is 1,889, with 347 from the parent company and 1,542 from major subsidiaries[179]. - The company has established a dual-channel career development path for employees, focusing on leadership, business, skills, and new employee training[182]. - The company has implemented measures to protect its core technologies, including patent applications and internal confidentiality protocols[123]. - The company is implementing a talent retention strategy through attractive compensation mechanisms and career development plans to stabilize its core talent team[126].
ST易联众:控股股东及其他关联方资金占用情况的专项说明
2024-04-25 16:50
易联众信息技术股份有限公司 控股股东及其他关联方资金占用情况的 专项说明 大华核字[2024]0011008131 号 大 华 会 计 师 事 务 所(特 殊 普 通 合 伙 ) Da Hua Certified Public Accountants (Special General Partnership ) 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台(http://ac.mo 易联众信息技术股份有限公司 控股股东及其他关联方资金占用情况的专项说明 (截止 2023 年 12 月 31 日 ) 页 次 录 ll 控股股东及其他关联方资金占用情况的专项 1 1-2 说明 1 Í 易联众信息技术股份有限公司 2023 年度非经 营性资金占用及其他关联资金往来情况汇总 表 1-2 大半會計師事務两 大华会计师事务所 (特殊普通合伙) 北京市海淀区西四环中路 16 号院 7 号楼 12 层 [100039] 电话: 86 (10) 5835 0011 传真: 86 (10) 5835 0006 www.dahua-cpa.com 控 股 股 东 及 其 他 关 联 方 资 金 占 用 情 况 的 专 ...
ST易联众:董事会薪酬与考核委员会实施细则(2024年4月)
2024-04-25 16:50
易联众信息技术股份有限公司 YLZ Information Technology Co.,Ltd 董事会薪酬与考核委员会实施细则 2024 年 4 月 1 易联众信息技术股份有限公司 董事会薪酬与考核委员会实施细则 第一章 总则 第一条 为进一步建立健全易联众信息技术股份有限公司(以下简称"公司") 薪酬与考核管理制度,完善公司治理结构,根据《中华人民共和国公司法》、《上 市公司治理准则》、《易联众信息技术股份有限公司章程》(以下简称《公司章 程》)及其他有关规定,公司特设立董事会薪酬与考核委员会,并制定本细则。 第二条 薪酬与考核委员会是董事会下设的专门委员会,主要负责制定公司 董事、高级管理人员的考核标准并进行考核,制定、审查公司董事、高级管理人 员的薪酬政策与方案,对董事会负责。 第三条 本细则所称董事是指公司的董事长、董事、独立董事;高级管理人 员是指董事会聘任的 CEO 及《公司章程》规定的其他高级管理人员。 第二章 人员组成 第四条 薪酬与考核委员会成员由董事组成,不得少于三人,独立董事应当 过半数并担任召集人。 第五条 薪酬与考核委员会委员由董事长或董事会提名委员会提名,并由董 事会以全体董事过 ...
ST易联众:内部审计制度(2024年4月)
2024-04-25 16:50
易联众信息技术股份有限公司 YLZ Information Technology Co.,Ltd 内部审计制度 2024 年 4 月 1 易联众信息技术股份有限公司 内部审计制度 第一章 总则 第一条 为了规范易联众信息技术股份有限公司(以下简称"公司")内部 审计工作,提高内部审计工作质量,保护投资者合法权益,依据有关法律、法规、 规章和深圳证券交易所的相关规定,制定本制度。 第二条 本制度所称内部审计,是指由公司内部机构或人员,对公司内部控 制和风险管理的有效性、财务信息的真实性、完整性以及经营活动的效率和效果 等开展的一种评价活动。 第三条 本制度所称内部控制,是指公司董事会、监事会、高级管理人员及 其他有关人员为实现下列目标而提供合理保证的过程: (一)遵守国家法律、法规、规章及其他相关规定; (二)提高公司经营的效率和效果; (三)保障公司资产的安全; (四)确保公司信息披露的真实、准确、完整和公平。 第二章 一般规定 第四条 公司在董事会下设立审计委员会,审计委员会成员应当为不在公司 担任高级管理人员的董事,其中独立董事应占半数以上并担任召集人,召集人应 当由独立董事担任且为会计专业人士。 第五条 ...
ST易联众:2023年度述职报告(卢永华)
2024-04-25 16:50
各位股东及股东代表: 2023 年度,本人作为易联众信息技术股份有限公司(以下简称"公司") 第五届董事会独立董事,任职期间严格按照《公司法》《证券法》《上市公司独 立董事管理办法》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上 市公司规范运作》《公司章程》《独立董事工作制度》等相关法律、法规、规章 的规定和要求,忠实、勤勉、独立地履行独立董事的职责,出席相关会议,认真 审议董事会各项议案,客观公正地对相关议案发表独立意见,积极发挥独立董事 作用,促进公司规范运作,切实维护公司整体利益和全体股东尤其是中小股东的 合法权益。现就本人 2023 年度履行职责情况报告如下: 一、基本情况 本人卢永华,男,生于 1954 年 12 月,中国国籍,会计学博士,会计学教授, 无永久境外居留权。1980 年 9 月至 1984 年 7 月,在厦门大学会计学专业就读, 获学士学位;1984 年 7 月厦门大学会计系毕业留校后一直从事会计教学、科研 工作;期间于 1992 年 7 月获得厦门大学会计系硕士学位;2002 年 6 月获厦门大 学管理学(会计学)博士学位。历任厦门大学会计系助教、厦门大学会计系讲师、 厦 ...
ST易联众:2023年度述职报告(张月波)
2024-04-25 16:50
易联众信息技术股份有限公司 2023 年度独立董事述职报告 各位股东及股东代表: 本人自 2023 年 2 月 6 日担任易联众信息技术股份有限公司(以下简称"公 司")第五届董事会独立董事以来,严格按照《公司法》《证券法》《上市公司 独立董事管理办法》《深圳证券交易所上市公司自律监管指引第 2 号——创业板 上市公司规范运作》等相关法律、法规、规章的规定和《公司章程》《独立董事 工作制度》等规章制度的要求,忠实、勤勉履行独立董事职责,维护公司和全体 股东的合法权益。现就本人 2023 年度任职期间履行职责情况报告如下: 一、基本情况 张月波,男,生于 1962 年 11 月,中国国籍,无永久境外居留权。硕士学历, 中共党员;高级会计师。2001 年 6 月毕业于北京大学法学院法学专业,获法学 硕士学位。1992年3月至1995年6月任中国农村发展信托投资公司财务处处长, 1983 年 7 月至 1992 年 3 月任中国建设银行北京分行西四支行会计科科长。1995 年 7 月加入中国民生银行,至 1996 年 1 月担任筹备组组员,于 1996 年 1 月至 1996 年 10 月担任总行会计部副主任,于 ...
ST易联众(300096) - 2024 Q1 - 季度财报
2024-04-25 16:48
Financial Performance - The company's revenue for Q1 2024 was ¥48,863,469.88, a decrease of 64.15% compared to ¥136,296,251.75 in the same period last year[3] - The net loss attributable to shareholders was ¥40,150,465.42, showing an improvement of 8.09% from a loss of ¥43,683,967.28 in the previous year[3] - Total operating revenue for Q1 2024 was CNY 48,863,469.88, a decrease of 64.1% compared to CNY 136,296,251.75 in the previous period[26] - Net loss for Q1 2024 was CNY 51,910,916.12, compared to a net loss of CNY 51,039,837.94 in the same period last year[28] - Total comprehensive income for the first quarter was -34,786,522.20 CNY, compared to -26,965,457.65 CNY in the previous period, reflecting a decline of approximately 29.5%[29] Cash Flow and Liquidity - The net cash flow from operating activities was -¥143,471,394.27, a decline of 90.42% compared to -¥75,344,658.27 in the same period last year[3] - Cash received from operating activities decreased to ¥21,321,209.82, a decline of 69.51% due to reduced labor dispatch business activities[11] - Cash inflow from sales of goods and services was 74,826,794.81 CNY, significantly lower than 158,719,772.50 CNY in the same period last year, a drop of about 52.9%[31] - Total cash outflow from operating activities was 240,676,743.16 CNY, compared to 307,429,354.67 CNY in the previous period, a decrease of approximately 21.7%[32] - Cash and cash equivalents decreased to CNY 259,078,294.02 from CNY 408,060,395.13 at the beginning of the period, a decline of 36.5%[22] Assets and Liabilities - The total assets decreased by 10.98% to ¥976,790,728.11 from ¥1,097,301,888.74 at the end of the previous year[3] - Total liabilities decreased to CNY 606,780,281.75 from CNY 680,744,469.48, a decrease of 10.9%[24] - The company’s total liabilities decreased significantly, with accounts payable to employees dropping by 44.38% to ¥53,846,167.58 from ¥96,802,766.22[8] - Accounts receivable decreased to CNY 185,330,550.41 from CNY 197,357,958.25, a decline of 6.4%[22] Research and Development - Research and development expenses were ¥12,210,612.04, down 55.04% from ¥27,159,324.46 in the previous year, attributed to personnel optimization and reduced R&D investment[9] - Research and development expenses for Q1 2024 were CNY 12,210,612.04, down 55.1% from CNY 27,159,324.46 in the previous period[26] Government Support and Subsidies - The company received government subsidies amounting to ¥9,554,071.73, which positively impacted other income, increasing by 42.82% compared to the previous year[9] Shareholder and Corporate Governance - The company’s major shareholder, Zhoukou Chengfa Intelligent Technology Co., Ltd., now holds 16.19% of the shares, becoming the controlling shareholder[19] - The company lost the right to appoint directors in its associate company, leading to a reclassification of its investment, which affected its financial results significantly[9] - The company’s stock continues to be under risk warning due to unresolved issues related to illegal guarantees and borrowings[20] Legal and Compliance Issues - The company is currently appealing a first-instance judgment related to a significant lawsuit, indicating ongoing legal challenges[19] - The company has not undergone an audit for the first quarter report, indicating that the figures are unaudited[34] Investment Activities - The company made an investment payment of ¥2,655,976.50, which is a substantial increase of 1,283.32% due to acquiring a 9.92% stake in a subsidiary[11] - The net cash flow from investment activities was -2,720,932.50 CNY, worsening from -158,551.09 CNY year-over-year, reflecting increased investment outflows[32] Taxation - Total taxes paid amounted to ¥10,783,983.42, reflecting a 43.24% decrease attributed to lower revenue[11] - The company reported a significant decrease in tax refunds received, totaling ¥1,057,344.26, down 69.15% compared to the previous period[11]